<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="bpa13121" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Pathol</journal-id><journal-id journal-id-type="iso-abbrev">Brain Pathol</journal-id><journal-id journal-id-type="pmc-domain-id">4024</journal-id><journal-id journal-id-type="pmc-domain">brainpath</journal-id><journal-id journal-id-type="publisher-id">BPA</journal-id><journal-title-group><journal-title>Brain Pathology</journal-title></journal-title-group><issn pub-type="ppub">1015-6305</issn><issn pub-type="epub">1750-3639</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10041075</article-id><article-id pub-id-type="pmcid-ver">PMC10041075.1</article-id><article-id pub-id-type="pmcaid">10041075</article-id><article-id pub-id-type="pmcaiid">10041075</article-id><article-id pub-id-type="pmid">36180818</article-id><article-id pub-id-type="doi">10.1111/bpa.13121</article-id><article-id pub-id-type="publisher-id">BPA13121</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Epilepsy&#8208;associated death in the Southwestern Ontario: A clinicopathological correlation study</article-title><alt-title alt-title-type="right-running-head">EPILEPSY DEATH IN SOUTHWESTERN ONTARIO</alt-title><alt-title alt-title-type="left-running-head">Zhang et al.</alt-title></title-group><contrib-group><contrib id="bpa13121-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="Q">Qi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4928-2742</contrib-id><xref rid="bpa13121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="bpa13121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>qzhan33@uwo.ca</email></address></contrib><contrib id="bpa13121-cr-0002" contrib-type="author"><name name-style="western"><surname>Suller&#8208;Marti</surname><given-names initials="A">Ana</given-names></name><xref rid="bpa13121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="bpa13121-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="bpa13121-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="bpa13121-cr-0003" contrib-type="author"><name name-style="western"><surname>Ding</surname><given-names initials="JJ">Jane Jian</given-names></name><xref rid="bpa13121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="bpa13121-cr-0004" contrib-type="author"><name name-style="western"><surname>Deng</surname><given-names initials="G">Gansen</given-names></name><xref rid="bpa13121-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="bpa13121-cr-0005" contrib-type="author"><name name-style="western"><surname>He</surname><given-names initials="W">Wenqing</given-names></name><xref rid="bpa13121-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="bpa13121-cr-0006" contrib-type="author"><name name-style="western"><surname>Burneo</surname><given-names initials="JG">Jorge G.</given-names></name><xref rid="bpa13121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="bpa13121-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="bpa13121-cr-0007" contrib-type="author"><name name-style="western"><surname>Hammond</surname><given-names initials="RR">Robert R.</given-names></name><xref rid="bpa13121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="bpa13121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="bpa13121-cr-0008" contrib-type="author"><name name-style="western"><surname>Ang</surname><given-names initials="LC">Lee&#8208;Cyn</given-names></name><xref rid="bpa13121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="bpa13121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="bpa13121-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology and Lab Medicine, London Health Sciences Centre</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="bpa13121-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="bpa13121-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics, Schulich School of Medicine and Dentistry</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="bpa13121-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry, Schulich School of Medicine and Dentistry</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="bpa13121-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Statistical and Actuarial Sciences</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="bpa13121-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Neuroepidemiology Unit, Schulich School of Medicine and Dentistry</named-content>
<institution>Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Qi Zhang, Department of Pathology and Laboratory Medicine, London Health Sciences Centre, Western University, London ON N6A 5A5, Canada.<break/>
Email: <email>qzhan33@uwo.ca</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2023</year></pub-date><volume>33</volume><issue seq="100">2</issue><issue-id pub-id-type="pmc-issue-id">432077</issue-id><issue-id pub-id-type="doi">10.1111/bpa.v33.2</issue-id><issue-title content-type="special-issue-title">Stroke Biomarkers</issue-title><elocation-id>e13121</elocation-id><history><date date-type="received"><day>24</day><month>4</month><year>2022</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>09</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-28 00:10:13.037"><day>28</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2022 The Authors. <italic toggle="yes">Brain Pathology</italic> published by John Wiley &amp; Sons Ltd on behalf of International Society of Neuropathology.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="BPA-33-e13121.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:BPA-33-e13121.pdf"/><abstract><title>Abstract</title><p>Patients with epilepsy are at elevated risk for premature mortality, of which sudden unexpected death in epilepsy (SUDEP) is one of the leading causes. SUDEP incidence varies significantly depending on the population and the methods used to document the cause of death. We performed retrospective case review at the London Health Sciences Centre for the period of 2000 to 2018. Clinical information, scene investigations, general pathology findings, toxicology, and neuropathology findings were obtained, examined, and confirmed by two neuropathologists and one epileptologist. The characteristics were compared and summarized. We also evaluated the impact of <italic toggle="no">2010 revision of Ontario Coroner Act Regulation</italic>, which significantly limited whole brain examination. Among the 12,206 cases reviewed, we identified 152 cases with a known history of epilepsy. Ninety&#8208;seven cases (64%) were classified as SUDEP. There were significantly more SUDEP decedents found dead unwitnessed at night in prone position, than non&#8208;SUDEP. Generalized seizures were strongly associated with SUDEP. A male predominance was observed in SUDEP group between 15 and 35&#8201;years old. Near half of the brains examined were &#8220;unremarkable.&#8221; There was no difference in neuropathology findings between SUDEP and non&#8208;SUDEP groups. After implementation of the <italic toggle="no">2010 revision of Ontario Coroner Act Regulation,</italic> fixed whole brain examination was reduced from 88% to 7% of the epilepsy&#8208;related death investigation. Except a lower diagnosis rate of &#8220;inflammatory/infectious changes,&#8221; there were no significant differences in neuropathology findings. This is the first detailed clinical&#8208;pathological study on epilepsy&#8208;related death based on a Canadian cohort. This study reinforces the previously reported findings in SUDEP and highlights the importance of clinicopathological correlation for accurate classification of epilepsy&#8208;related death.</p></abstract><abstract abstract-type="graphical"><p>SUDEP is the most common cause of death identified for the Southwestern Ontario cohort. The age at death (AAD) of both SUDEP and non&#8208;SUDEP peaked at around 45&#8201;years old. There are significantly more SUDEPs for the 15&#8211;35&#8201;years old age group, which is only observed in male decedents, but not females.<boxed-text position="anchor" content-type="graphic" id="bpa13121-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="BPA-33-e13121-g004.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="bpa13121-kwd-0001">autopsy</kwd><kwd id="bpa13121-kwd-0002">epilepsy</kwd><kwd id="bpa13121-kwd-0003">neuropathology</kwd><kwd id="bpa13121-kwd-0004">sudden death</kwd><kwd id="bpa13121-kwd-0005">SUDEP</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Lawson Health Research Institute
</institution><institution-id institution-id-type="doi">10.13039/100008958</institution-id></institution-wrap></funding-source><award-id>Lawson IRF&#8208;38&#8208;18</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Ontario Brain Institute
</institution><institution-id institution-id-type="doi">10.13039/100008914</institution-id></institution-wrap></funding-source><award-id>the Epilepsy Research Program (EpLink)</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Schulich School of Medicine and Dentistry, Western University
</institution><institution-id institution-id-type="doi">10.13039/501100022104</institution-id></institution-wrap></funding-source><award-id>Schulich CRSG</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>Western University
</institution><institution-id institution-id-type="doi">10.13039/501100004381</institution-id></institution-wrap></funding-source><award-id>WSS&#8208;CIHR Seed grant</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="3"/><page-count count="13"/><word-count count="7411"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.6 mode:remove_FC converted:27.03.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="bpa13121-cit-9001"><string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Suller&#8208;Marti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Burneo</surname><given-names>JG</given-names></string-name>, et al. <article-title>Epilepsy&#8208;associated death in the Southwestern Ontario: A clinicopathological correlation study</article-title>. <source>Brain Pathology</source>. <year>2023</year>;<volume>33</volume>(<issue>2</issue>):<elocation-id>e13121</elocation-id>. <pub-id pub-id-type="doi">10.1111/bpa.13121</pub-id><pub-id pub-id-type="pmcid">PMC10041075</pub-id><pub-id pub-id-type="pmid">36180818</pub-id></mixed-citation>
</p><fn-group><fn id="bpa13121-note-1002"><p>
<bold>Funding information</bold> Lawson Health Research Institute, Grant/Award Number: Lawson IRF&#8208;38&#8208;18; Ontario Brain Institute, Grant/Award Number: the Epilepsy Research Program (EpLink); Schulich School of Medicine and Dentistry, Western University, Grant/Award Number: Schulich CRSG; Western University, Grant/Award Number: WSS&#8208;CIHR Seed grant</p></fn></fn-group></notes></front><body id="bpa13121-body-0001"><sec id="bpa13121-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Premature mortality among epilepsy patients is well recognized. Patients with epilepsy are at increased risk (threefold) of unnatural death compared to the general population [<xref rid="bpa13121-bib-0001" ref-type="bibr">1</xref>, <xref rid="bpa13121-bib-0002" ref-type="bibr">2</xref>]. Except for a few identifiable causes of unnatural death, such as drowning, choking, or drug overdose, more than half of the epilepsy&#8208;related death remains unexplained after extensive investigation. Sudden unexpected death in epilepsy (SUDEP) is determined after all known causes have been excluded. SUDEP is defined as &#8220;sudden, unexpected, witnessed or unwitnessed, nontraumatic and non&#8208;drowning death in patients with epilepsy, with or without evidence for a seizure and excluding documented status epilepticus, in which postmortem examination does not reveal a toxicologic or anatomic cause of death&#8221; [<xref rid="bpa13121-bib-0003" ref-type="bibr">3</xref>]. SUDEP is more common in young adults (20&#8211;45&#8201;years old) [<xref rid="bpa13121-bib-0004" ref-type="bibr">4</xref>]. Despite increased research efforts, the incidence, mechanism, and predictive biomarkers remain largely unknown, leading to a lack of effective prevention strategies against SUDEP.</p><p>SUDEP incidence varies significantly depending on the population studied and the methods used to document cause of death. Diagnosis of SUDEP is further complicated by cases with incomplete information and cases with competing causes of death. Recent updates in SUDEP classification and diagnosis criteria are proposed to capture all SUDEP cases and resolve ambiguities [<xref rid="bpa13121-bib-0003" ref-type="bibr">3</xref>, <xref rid="bpa13121-bib-0005" ref-type="bibr">5</xref>]. In brief, SUDEP cases are divided into three groups: (1) definite SUDEP, when all investigation and complete postmortem examination (including toxicology) reveal no other cause of death; (2) probable SUDEP, when criteria for definite SUDEP are met but no or limited autopsy (external examination only, extensive decomposition, etc.) is performed; (3) possible SUDEP, when there is competing cause of death. In addition, when there is comorbidity and death may be attributed to the combination of both, a case is classified as SUDEP Plus (either definite or probable SUDEP Plus).</p><p>It is believed that SUDEP is under&#8208;recognized by primary health practitioners, coroners, or medical examiners [<xref rid="bpa13121-bib-0006" ref-type="bibr">6</xref>, <xref rid="bpa13121-bib-0007" ref-type="bibr">7</xref>, <xref rid="bpa13121-bib-0008" ref-type="bibr">8</xref>]. An accurate diagnosis of the cause of death is therefore needed for epilepsy&#8208;related death. The goal of this study is to present the relevant clinical information, general autopsy, and neuropathology findings of epilepsy&#8208;related death in Southwestern Ontario over a time frame of 18&#8201;years.</p></sec><sec sec-type="materials-and-methods" id="bpa13121-sec-0002"><label>2</label><title>MATERIAL AND METHODS</title><sec id="bpa13121-sec-0003"><label>2.1</label><title>Standard protocol approvals, study design, and data collection</title><p>This study was approved by the research ethics board of Western University (HSREB 101967). All autopsies were conducted under the Coroner's warrant or complete autopsy consent. We reviewed all autopsy cases performed at the London Health Sciences Centre (LHSC) for the period of 2000 to 2018 and identified 152 cases with known history of epilepsy. Keywords &#8220;seizure&#8221; and &#8220;epilepsy&#8221; were used for case search. Some of these cases were re&#8208;categorized according to the recently proposed SUDEP Definition and Classification [<xref rid="bpa13121-bib-0003" ref-type="bibr">3</xref>, <xref rid="bpa13121-bib-0005" ref-type="bibr">5</xref>]. As described by Devinsky et al., cases with concomitant cardiac disorders were among the most ambiguous group and were often subject to re&#8208;classification [<xref rid="bpa13121-bib-0005" ref-type="bibr">5</xref>]. For example, for patients with epilepsy and severe coronary atherosclerosis (&gt;80% stenosis), cause of death was often attributed to coronary artery disease. We acknowledged the challenges to distinguish terminal cardiac arrhythmia and epileptogenic death, and therefore re&#8208;classified these cases as possible SUDEP.</p><p>Clinical information and scene investigations were obtained from the Coroner's warrant, neuropathology consultation request, and medical record if available. General pathology findings, toxicology, and neuropathology findings were obtained from the final autopsy reports. The toxicology analyses were performed on postmortem blood at the Ontario Centre of Forensic Sciences to determine the absence/presence/concentration of drugs, including alcohol and poisons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ontario.ca/cfs" ext-link-type="uri">www.ontario.ca/cfs</ext-link>).</p></sec><sec id="bpa13121-sec-0004"><label>2.2</label><title>Statistical analysis</title><p>Statistical analysis was performed using R statistical software. Continuous data were compared between groups using the Mann&#8211;Whitney test. Comparison of discrete variables was performed using Fisher's exact test. Significance was conferred when <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec sec-type="results" id="bpa13121-sec-0005"><label>3</label><title>RESULTS</title><p>Among the 12,206 autopsies performed at the LHSC during 2000 to 2018, there were 152 cases identified with documented epilepsy history.</p><p>Deaths were adjudicated as definite SUDEP, definite SUDEP plus, probable SUDEP, probable SUDEP plus, possible SUDEP, or near SUDEP based on modified SUDEP criteria and recommendations [<xref rid="bpa13121-bib-0003" ref-type="bibr">3</xref>, <xref rid="bpa13121-bib-0005" ref-type="bibr">5</xref>]. Among the 152 epilepsy decedents, the causes of death were attributed to SUDEP in 97 cases (64%): definite SUDEP (76, 78.4%), definite SUDEP plus (11, 11.3%), probable SUDEP (2, 2.1%), possible SUDEP (12, 12.4%).</p><p>There were 55 cases (36%) with identifiable CODs (non&#8208;SUDEP). Pulmonary disorders (pneumonia, pulmonary embolism) were the most common non&#8208;SUDEP causes of death, followed by cardiac (acute myocardial infarct), drug overdose, trauma, and drowning. Other identifiable CODs were less common, including gastrointestinal bleeding, sepsis, ketoacidosis, multi&#8208;organ failure, smoke inhalation, and choking (Figure&#160;<xref rid="bpa13121-fig-0001" ref-type="fig">1A,B</xref>).</p><fig position="float" fig-type="FIGURE" id="bpa13121-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Cause of death and age distribution of the time at death. (A, B) SUDEP is the most common (64%) cause of death identified for the Southwestern Ontario cohort. (C) The age at death (AAD) of both SUDEP and non&#8208;SUDEP peaks at around 45&#8201;years old. The density of AAD starts to increase at 15&#8201;years old in SUDEP group, but not until 30&#8201;years old in non&#8208;SUDEP group, leading to significantly more SUDEPs for the 15&#8211;35&#8201;years old age group (boxed area). (D) This difference is only observed in male decedents, but not females.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="BPA-33-e13121-g005.jpg"/></fig><sec id="bpa13121-sec-0006"><label>3.1</label><title>Clinical information and patient demographic characteristics</title><sec id="bpa13121-sec-0007"><label>3.1.1</label><title>Demographics</title><p>Among 152 patients with a history of epilepsy, fifty&#8208;nine (38.8%) were females. The median age was 41&#8201;years old (IQR&#160;=&#160;21.5&#8211;50.5).</p><p>The age at death (AAD) for both SUDEP and non&#8208;SUDEP groups peaked at around 45&#8201;years old. The median AADs were comparable for these two groups, being 39&#8201;years old (IQR&#160;=&#160;20&#8211;50) in the SUDEP group and 41.5&#8201;years old (IQR&#160;=&#160;21.25&#8211;51.25) in the non&#8208;SUDEP group. However, upon examining the AAD distribution over time of the two groups, the density of AAD for SUDEPs started to increase as early as 15&#8201;years. A similar trend was only observed after 30&#8201;years of age in the non&#8208;SUDEP group. Significantly more deaths occurred at the age group between 15 and 35&#8201;years old in the SUDEP group when compared to non&#8208;SUDEP (<italic toggle="yes">p</italic>&#160;=&#160;0.04; Figure&#160;<xref rid="bpa13121-fig-0001" ref-type="fig">1C</xref>). Interestingly, this difference was mainly driven by male decedents in the SUDEP group. For female epilepsy decedents, the trends were similar among all age groups in both SUDEP and non&#8208;SUDEP (Figure&#160;<xref rid="bpa13121-fig-0001" ref-type="fig">1D</xref>).</p></sec><sec id="bpa13121-sec-0008"><label>3.1.2</label><title>Seizure and epilepsy treatment history</title><p>The median age of epilepsy onset was 10&#8201;years (IQR&#160;=&#160;2&#8211;23.3) in the SUDEP group compared to 16.5&#8201;years (IQR&#160;=&#160;1&#8211;44) in the non&#8208;SUDEP group; however, there was no statistical difference between the two groups (Table&#160;<xref rid="bpa13121-tbl-0001" ref-type="table">1</xref>). Twenty&#8208;three (23.7%) of SUDEP patients and 13 (23.6%) of non&#8208;SUDEP patients possessed at least one risk factor predisposing them to seizures, including history of febrile seizures (<italic toggle="yes">n</italic>&#160;=&#160;6, 16.6%), previous head trauma (<italic toggle="yes">n</italic>&#160;=&#160;6, 16.6%), and family history of epilepsy (<italic toggle="yes">n</italic>&#160;=&#160;5, 13.8%). Episodes of status epilepticus were only documented in seven (7.2%) of SUDEP patients and one (1.8%) non&#8208;SUDEP patient, with no significant differences between the two groups. Generalized seizures were significantly more common in SUDEP cases and were documented in 42 (43.2%) of SUDEP patients compared to 14 (25.5%) of non&#8208;SUDEP patients.</p><table-wrap position="float" id="bpa13121-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary of clinical information</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">SUDEP <italic toggle="yes">n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Non&#8208;SUDEP <italic toggle="yes">n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (median in years)</td><td align="char" valign="top" rowspan="1" colspan="1">39 (IQR&#160;=&#160;20&#8211;50)</td><td align="char" valign="top" rowspan="1" colspan="1">41.5 (IQR&#160;=&#160;21.3&#8211;51.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.684</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Epilepsy Onset (median in years)</td><td align="char" valign="top" rowspan="1" colspan="1">10 (IQR&#160;=&#160;2&#8211;23.3)</td><td align="char" valign="top" rowspan="1" colspan="1">16.5 (IQR&#160;=&#160;1&#8211;44)</td><td align="char" valign="top" rowspan="1" colspan="1">0.451</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration of epilepsy (median in years)</td><td align="char" valign="top" rowspan="1" colspan="1">8 (IQR&#160;=&#160;4&#8211;22.3)</td><td align="char" valign="top" rowspan="1" colspan="1">4.5 (IQR&#160;=&#160;2.3&#8211;23.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.338</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female sex</td><td align="char" valign="top" rowspan="1" colspan="1">40 (41.3)</td><td align="char" valign="top" rowspan="1" colspan="1">19 (34.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.489</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Clinical history</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">History of epilepsy risk factors</td><td align="char" valign="top" rowspan="1" colspan="1">23 (23.7)</td><td align="char" valign="top" rowspan="1" colspan="1">13(23.6)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">History of status epilepticus</td><td align="char" valign="top" rowspan="1" colspan="1">7 (7.2)</td><td align="char" valign="top" rowspan="1" colspan="1">1(1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.259</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">History of generalized seizures</td><td align="char" valign="top" rowspan="1" colspan="1">42 (43.2)</td><td align="char" valign="top" rowspan="1" colspan="1">14(25.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0357</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Seizure frequency</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Seizure freedom 3&#8211;6&#8201;m</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">10 (18.2)</td><td align="char" valign="top" rowspan="1" colspan="1">0.000728</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#8804;1 Seizure/m</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0900</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2&#8211;5 Seizures/m</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.236</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">6&#8211;10 Seizures/m</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.535</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&gt;10 Seizures/m</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Recent deterioration in seizure control</td><td align="char" valign="top" rowspan="1" colspan="1">12 (12.4)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.258</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Comorbidities</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">General conditions</td><td align="char" valign="top" rowspan="1" colspan="1">25 (25.8)</td><td align="char" valign="top" rowspan="1" colspan="1">27 (49.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.00452</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cardiovascular comorbidities</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Intellectual disabilities</td><td align="char" valign="top" rowspan="1" colspan="1">4 (4.1)</td><td align="char" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.461</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Psychiatric conditions</td><td align="char" valign="top" rowspan="1" colspan="1">27 (27.8)</td><td align="char" valign="top" rowspan="1" colspan="1">11 (20.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.333</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">History of substance misuse</td><td align="char" valign="top" rowspan="1" colspan="1">13 (13.4)</td><td align="char" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.603</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Past investigations</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">EEG</td><td align="char" valign="top" rowspan="1" colspan="1">36 (37.1)</td><td align="char" valign="top" rowspan="1" colspan="1">8 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.00303</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" valign="top" rowspan="1" colspan="1">19 (19.6)</td><td align="char" valign="top" rowspan="1" colspan="1">16 (29.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.229</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MRI</td><td align="char" valign="top" rowspan="1" colspan="1">28 (28.9)</td><td align="char" valign="top" rowspan="1" colspan="1">18 (32.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.713</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Abnormalities on MRI</td><td align="char" valign="top" rowspan="1" colspan="1">17 (17.5)</td><td align="char" valign="top" rowspan="1" colspan="1">14 (25.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.296</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">EMU admission</td><td align="char" valign="top" rowspan="1" colspan="1">4 (4.1)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Intracranial electrodes</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Treatment history</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Epilepsy surgery</td><td align="char" valign="top" rowspan="1" colspan="1">7 (7.2)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0491</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Neuromodulation</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antiseizure drugs (ASD)</td><td align="char" valign="top" rowspan="1" colspan="1">50 (51.5)</td><td align="char" valign="top" rowspan="1" colspan="1">30 (54.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.739</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Type of ASD</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Phenobarbital</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.589</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Phenytoin</td><td align="char" valign="top" rowspan="1" colspan="1">24 (24.7)</td><td align="char" valign="top" rowspan="1" colspan="1">11 (20.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.167</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Valproic Acid</td><td align="char" valign="top" rowspan="1" colspan="1">9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">8 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.422</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Carbamazepine</td><td align="char" valign="top" rowspan="1" colspan="1">9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lamotrigine</td><td align="char" valign="top" rowspan="1" colspan="1">12 (12.4)</td><td align="char" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.603</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Levetiracetam</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.554</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lacosamide</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.423</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Eslicarbazepine</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Brivaracetam</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Perampanel</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Clobazam</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Topiramate</td><td align="char" valign="top" rowspan="1" colspan="1">4 (4.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.654</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Vigabatrin</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.362</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Oxcarbazepine</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.129</td></tr></tbody></table></table-wrap><p>With respect to investigations, EEG records were available for a significantly greater proportion of SUDEP patients (<italic toggle="yes">n</italic>&#160;=&#160;36, 77.1%), compared to eight (14.5%) of non&#8208;SUDEP patients. There was no significant difference in number of patients who had received CT or MRI scans between the two groups. Among the decedents who had neuroimaging, there was no difference in the rate of abnormal findings documented on MRI for the two patient groups, with abnormal findings occurring in 17 (17.5%) of SUDEP patients and 14 (25.5%) of non&#8208;SUDEP patients. Few patients were admitted to the Epilepsy Monitoring Unit (EMU) during their lifetime, namely four (4.1%) SUDEP patients and two (3.6%) non&#8208;SUDEP. Similarly, few patients were investigated with intracranial electrodes, with three (3.1%) incidences documented in SUDEP cases and one (1.8%) in non&#8208;SUDEP.</p><p>There were no significant differences between the two groups with respect to medical management. Documented antiseizure drugs (ASDs) the patient was taking at the time of death were available for 50 (51.5%) SUDEP patients and 30 (54.4%) non&#8208;SUDEP patients. Phenytoin was the most common ASD in both groups. There were no significant differences in the ASDs taken between the two groups (Table&#160;<xref rid="bpa13121-tbl-0001" ref-type="table">1</xref>). Interestingly, significantly more SUDEP patients had received surgery for management of their epilepsy (<italic toggle="yes">n</italic>&#160;=&#160;7, 7.2%) (Table&#160;<xref rid="bpa13121-tbl-0001" ref-type="table">1</xref>). There was no difference in neuromodulation treatments, such as vagus nerve stimulation and deep brain stimulation (see Ding et al. [<xref rid="bpa13121-bib-0009" ref-type="bibr">9</xref>] for details).</p><p>The most frequent type of seizures was generalized, in 43.2% (<italic toggle="yes">n</italic>&#160;=&#160;42) of the total SUDEP cases, which was significantly higher than the non&#8208;SUDEP group (<italic toggle="yes">n</italic>&#160;=&#160;14, 25.5%). Generalized tonic&#8211;clonic seizures were identified in 77.5% (<italic toggle="yes">n</italic>&#160;=&#160;31) and absence seizures in 22.5% (<italic toggle="yes">n</italic>&#160;=&#160;9) of the patients with generalized epilepsy. The most common type of focal seizure found was focal seizures with progression to bilateral tonic&#8211;clonic (<italic toggle="yes">n</italic>&#160;=&#160;9, 50%), followed by focal motor seizures (<italic toggle="yes">n</italic>&#160;=&#160;4, 22%). Although not statistically significant, SUDEP decedents appeared to have worse seizure control. Ten (18.2%) of non&#8208;SUDEP patients were documented as seizure free for 3&#8211;6&#8201;months prior to death, whereas only two patients (2.1%) in the SUDEP group had achieved the same degree of seizure control. A recent deterioration in seizure control over the last month of life was documented in 12 (12.4%) of SUDEP patients, but only three (5.5%) of non&#8208;SUDEP patients (Table&#160;<xref rid="bpa13121-tbl-0001" ref-type="table">1</xref>). With the limited data available regarding treatment compliance, a definite history of &#8220;poor compliance&#8221; was found in 20% (<italic toggle="yes">n</italic>&#160;=&#160;15) of the SUDEP cases, almost double when compared to non&#8208;SUDEP, but this is not a significant difference.</p></sec><sec id="bpa13121-sec-0009"><label>3.1.3</label><title>Comorbidities</title><p>General medical conditions, including hypertension and diabetes, were significantly more common in non&#8208;SUDEP patients, and were present in 27 (49.0%) of individuals compared to 25 (25.8%) SUDEP individuals (Table&#160;<xref rid="bpa13121-tbl-0001" ref-type="table">1</xref>). Psychiatric comorbidities were identified in 27.8% (<italic toggle="yes">n</italic>&#160;=&#160;27) of SUDEP cases, of which the most frequent was a history of substance misuse in 13 (13.4%). In non&#8208;SUDEP cases, psychiatric comorbidities were found in 20.0% (<italic toggle="yes">n</italic>&#160;=&#160;11), with no statistical difference when compared to the SUDEP group. The most frequently documented misused substance was alcohol in 81.8% (<italic toggle="yes">n</italic>&#160;=&#160;9). In general, patients with SUDEP had fewer comorbidities (25.8%, <italic toggle="yes">n</italic>&#160;=&#160;25.8) than non&#8208;SUDEP patients (50%, <italic toggle="yes">n</italic>&#160;=&#160;29).</p></sec></sec><sec id="bpa13121-sec-0010"><label>3.2</label><title>Circumstances of death</title><p>When compared with non&#8208;SUDEP, SUDEP cases were more often unwitnessed and occurred at night (Figure&#160;<xref rid="bpa13121-fig-0002" ref-type="fig">2</xref>). The SUDEP decedents were most commonly found in prone position (<italic toggle="yes">n</italic>&#160;=&#160;27, 29.6%), which is significantly higher than the non&#8208;SUDEP cases (<italic toggle="yes">n</italic>&#160;=&#160;2, 3.3%). The majority of epilepsy decedents were found at home. In the SUDEP group, bodies were most commonly discovered in the bedroom, either in bed or on the floor adjacent to the bed (Figure&#160;<xref rid="bpa13121-fig-0002" ref-type="fig">2</xref>). The body was discovered in the bathtub in four cases, all of which were non&#8208;SUDEP. Seven additional cases were found on the floor of bathroom.</p><fig position="float" fig-type="FIGURE" id="bpa13121-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Circumstances of death in both SUDEP and non&#8208;SUDEP</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="BPA-33-e13121-g006.jpg"/></fig><p>For the 18 cases where death occurred in the hospital, the vast majority (17 of 18) died of identifiable causes (non&#8208;SUDEP).</p></sec><sec id="bpa13121-sec-0011"><label>3.3</label><title>Postmortem findings</title><sec id="bpa13121-sec-0012"><label>3.3.1</label><title>General autopsy and toxicology</title><p>Despite thorough examination, most (<italic toggle="yes">n</italic>&#160;=&#160;102, 67%) of the cases of epilepsy&#8208;related death had no significant structural findings at general autopsy. Evidences of recent seizure activity were recorded in 51 cases (33%), including bite marks and abrasions of the tongue and buccal mucosa. Nonspecific pulmonary edema was the most common pulmonary finding. Other findings such as bronchopneumonia, gastric contents aspiration, and pulmonary thromboemboli were also reported in individual cases. Cardiac findings, including moderate to severe coronary artery disease, cardiomegaly, aortic valve stenosis, and myocardial infarct were identified.</p><p>Postmortem toxicology screening was performed on all cases. Seven cases showed a fatal level of one or more illicit drugs. Multi&#8208;drug toxicity was more common than single drug overdose. Substances identified included ethanol, morphine, hydromorphone, methadone, and cocaine. Amitriptyline, a common antidepressant medication, was found at fatal level in two cases.</p></sec><sec id="bpa13121-sec-0013"><label>3.3.2</label><title>Neuropathology</title><p>For all the epilepsy death included in this study, the brains were examined by at least one neuropathologist and Neuropathology Autopsy Reports were available.</p><sec id="bpa13121-sec-0014"><title>Tissue sampling</title><p>Prior to the revision of <italic toggle="yes">Ontario Coroner Act Regulation</italic> in June 2010 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ontario.ca/laws/regulation/900180/v5" ext-link-type="uri">https://www.ontario.ca/laws/regulation/900180/v5</ext-link>), the majority of the neuropathology examination was performed on fixed whole brain (61/69, 88.4%) for epilepsy&#8208;related death investigation. After June 2010, only less than 7.2% (6/83) of the neuropathology examinations were carried out on whole brains. Of these whole brain referrals, most of the cases had known clinical history of developmental delay and abnormal neuroimaging findings. The rest of the brains were examined and sectioned freshly at time of autopsy. Selected brain slices were fixed and further sampled post formalin fixation. Overall, the brain regions examined (neocortex, amygdala, hippocampus, cerebellum, basal ganglia, thalamus, brainstem) were comparable before and after the implementation of the 2010 <italic toggle="yes">Ontario Coroner Act</italic> revision. There was a significant decrease of the cerebellar sampling after 2010. Interestingly, there was an increase in sampling of insula, anterior cingulate, amygdala, and pons (Figure&#160;<xref rid="bpa13121-fig-0003" ref-type="fig">3A</xref>). We further evaluated the neuropathological abnormalities identified in relation to this sampling protocol change. There were no significant differences in the gross findings, with near half of the cases recorded as &#8220;macroscopically unremarkable&#8221; (38.5% and 39.1%, respectively). The microscopic findings were also comparable, except a lower &#8220;inflammatory/infectious changes&#8221; reported after 2010 (Figure&#160;<xref rid="bpa13121-fig-0003" ref-type="fig">3B</xref>).</p><fig position="float" fig-type="FIGURE" id="bpa13121-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Neuropathology findings before and after the implementation of <italic toggle="yes">2010 Ontario Coroner Act Regulation revision</italic>. (A) There is a significant reduction in whole brain referral after June 2010. Majority of the essential brain regions are examined, except a reduction in cerebellar sampling after 2010. (B) Less inflammatory/infectious changes are identified after 2010, but the overall neuropathology findings are comparable.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="BPA-33-e13121-g003.jpg"/></fig></sec><sec id="bpa13121-sec-0015"><title>Macroscopic examination</title><p>Nearly half (44.7%) of the brains examined were recorded as grossly unremarkable. There was a slightly higher &#8220;unremarkable&#8221; rate in the SUDEP group in comparison to the non&#8208;SUDEP group (49.5% and 36.4%, respectively) (Table&#160;<xref rid="bpa13121-tbl-0002" ref-type="table">2</xref>). Focal lesions were detected in 32 cases (21%). Encephaloclastic lesions (polymicrogyria, ulegyria, porencephaly, leukomalacia), neuronal heterotopia, hippocampal abnormalities (malrotation, atrophy/sclerosis, asymmetry), and old contusions were among the most commonly identified gross abnormalities. Fresh brain weight was recorded for all cases, which was within normal limits for vast majority of the cases.</p><table-wrap position="float" id="bpa13121-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Summary of neuropathology findings</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">SUDEP <italic toggle="yes">n</italic>, (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Non&#8208;SUDEP <italic toggle="yes">n</italic>, (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Brain weight (gram, mean&#8201;&#177;&#8201;SD)</td><td align="char" valign="top" rowspan="1" colspan="1">Median: 1330 (IQR&#160;=&#160;1211&#8211;1480.5)</td><td align="char" valign="top" rowspan="1" colspan="1">Median: 1350 (IQR&#160;=&#160;1211.5&#8211;1482)</td><td align="char" valign="top" rowspan="1" colspan="1">0.975</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gross findings</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Normal</td><td align="char" valign="top" rowspan="1" colspan="1">48 (49.5)</td><td align="char" valign="top" rowspan="1" colspan="1">20 (36.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.130</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Abnormal</td><td align="char" valign="top" rowspan="1" colspan="1">35 (36.1)</td><td align="char" valign="top" rowspan="1" colspan="1">24 (43.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.390</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Unknown</td><td align="char" valign="top" rowspan="1" colspan="1">14 (14.4)</td><td align="char" valign="top" rowspan="1" colspan="1">11 (20.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.374</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neuropathology diagnosis</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#8220;Epileptogenic&#8221; lesions</td><td align="char" valign="top" rowspan="1" colspan="1">45 (46.4)</td><td align="char" valign="top" rowspan="1" colspan="1">19 (34.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.174</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Nonspecific findings</td><td align="char" valign="top" rowspan="1" colspan="1">56 (57.7)</td><td align="char" valign="top" rowspan="1" colspan="1">35 (63.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.496</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Secondary changes</td><td align="char" valign="top" rowspan="1" colspan="1">12 (12.4)</td><td align="char" valign="top" rowspan="1" colspan="1">12 (21.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.165</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Inflammatory/infectious changes</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.135</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Other</td><td align="char" valign="top" rowspan="1" colspan="1">15 (15.5)</td><td align="char" valign="top" rowspan="1" colspan="1">7 (12.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.811</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">No pathological abnormality</td><td align="char" valign="top" rowspan="1" colspan="1">9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8220;Epileptogenic&#8221; lesions</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Malformations</td><td align="char" valign="top" rowspan="1" colspan="1">17 (17.5)</td><td align="char" valign="top" rowspan="1" colspan="1">8 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.820</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mesial temporal sclerosis</td><td align="char" valign="top" rowspan="1" colspan="1">14 (14.4)</td><td align="char" valign="top" rowspan="1" colspan="1">7 (12.7)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Perinatal hypoxia&#8208;ischemia injuries</td><td align="char" valign="top" rowspan="1" colspan="1">7 (7.2)</td><td align="char" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.758</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CNS trauma (chronic)</td><td align="char" valign="top" rowspan="1" colspan="1">10 (10.3)</td><td align="char" valign="top" rowspan="1" colspan="1">6 (10.9)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Surgical scars</td><td align="char" valign="top" rowspan="1" colspan="1">9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.770</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Old infarct</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.621</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Vascular malformations</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tumors</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.129</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mesial temporal sclerosis</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Right</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.712</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Left</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.297</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Bilateral</td><td align="char" valign="top" rowspan="1" colspan="1">5 (5.2)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">NOS</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Malformation types</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Focal cortical dysplasia</td><td align="char" valign="top" rowspan="1" colspan="1">7 (7.2)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.489</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Heterotopia</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Microcephaly</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Pontocerebellar hypoplasia</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.129</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vascular malformations</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cavernous hemangioma</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Perinatal hypoxia&#8208;ischemia</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ulegyria</td><td align="char" valign="top" rowspan="1" colspan="1">5 (5.2)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.419</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Porencephaly</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Status marmoratus</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Polymicrogyria</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.129</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cystic encephalomalacia</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.9)</td><td align="char" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Other</td><td align="char" valign="top" rowspan="1" colspan="1">2 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.538</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tumors</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diffuse astrocytoma</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.362</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Craniopharyngioma</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.362</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic CNS trauma</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Contusion or laceration</td><td align="char" valign="top" rowspan="1" colspan="1">9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">2 (3.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.329</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Subdural hemorrhage</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.668</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nonspecific findings</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Brain swelling</td><td align="char" valign="top" rowspan="1" colspan="1">6 (6.2)</td><td align="char" valign="top" rowspan="1" colspan="1">7 (12.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.227</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Hypoxic&#8211;ischemic encephalopathy</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">6 (10.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0722</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Clasmatodendrosis</td><td align="char" valign="top" rowspan="1" colspan="1">18 (18.6)</td><td align="char" valign="top" rowspan="1" colspan="1">3 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0277</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Gliosis</td><td align="char" valign="top" rowspan="1" colspan="1">17 (17.5)</td><td align="char" valign="top" rowspan="1" colspan="1">4 (7.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.0909</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Metabolic encephalopathy</td><td align="char" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="char" valign="top" rowspan="1" colspan="1">1 (1.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.362</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Neurodegenerative changes</td><td align="char" valign="top" rowspan="1" colspan="1">3 (3.1)</td><td align="char" valign="top" rowspan="1" colspan="1">5 (9.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.139</td></tr></tbody></table></table-wrap></sec><sec id="bpa13121-sec-0016"><title>Microscopic examination</title><p>Less than half of the neuropathology examinations revealed potential &#8220;epileptogenic&#8221; or epilepsy&#8208;related lesions. CNS malformations, hippocampal sclerosis (HS), pathological changes associated with perinatal hypoxic&#8211;ischemic encephalopathies (encephaloclastic lesions), and remote CNS trauma were the most commonly identified microscopic abnormalities (Table&#160;<xref rid="bpa13121-tbl-0002" ref-type="table">2</xref>).</p><sec id="bpa13121-sec-0017"><title>Hippocampal abnormalities</title><p>Hippocampal sclerosis (HS) was found in 13.2% of all epilepsy&#8208;related death cases, and was slightly more common on the right side. Segmental loss of pyramidal neurons in both CA1 and CA4 sectors (ILAE type 1) was the most common histology finding in HS. Other patterns of HS were also observed, ranging from severe neuronal loss in all fields to neuronal loss/gliosis in CA4 only (also known as end folium sclerosis, ILAE type 3). Granule cell dispersion or bilamination in the dentate gyrus was also identified. There were no differences in the prevalence of HS between the SUDEP and non&#8208;SUDEP groups (14.4% and 12.7%, respectively). Other hippocampal abnormalities, such as asymmetry, malrotation, or hyper&#8208;convolution of the hippocampus, were also noted both macro&#8208; and microscopically (Figure&#160;<xref rid="bpa13121-fig-0004" ref-type="fig">4</xref>) [<xref rid="bpa13121-bib-0010" ref-type="bibr">10</xref>, <xref rid="bpa13121-bib-0011" ref-type="bibr">11</xref>, <xref rid="bpa13121-bib-0012" ref-type="bibr">12</xref>].</p><fig position="float" fig-type="FIGURE" id="bpa13121-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Examples of neuropathology findings in epilepsy&#8208;associated deaths. (A&#8211;C) Bilateral hippocampal malformation in a 23&#8208;year&#8208;old male died of SUDEP. There are hyper&#8208;convoluted CA1 and subiculum. The left side (B) is more severe than the right side (C). (D&#8211;F) A 40&#8208;year&#8208;old female with perinatal hypoxic&#8211;ischemic injury. There are multi&#8208;focal nodular grey matter heterotopia (arrows in D, asterisk in E), polymicrogyria (F), and hippocampal sclerosis (circle in D). Scale bar in F&#160;=&#160;3&#8201;mm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="BPA-33-e13121-g002.jpg"/></fig></sec><sec id="bpa13121-sec-0018"><title>CNS malformation</title><p>CNS malformations were identified in 16.4% of the neuropathological examinations, with the majority of the cases being focal cortical dysplasia and neuronal heterotopia (Figure&#160;<xref rid="bpa13121-fig-0004" ref-type="fig">4</xref>). There were no differences in the malformation prevalence between the SUDEP and non&#8208;SUDEP groups (17.5% and 14.5%, respectively). Subtle CNS malformations, particularly hippocampal malrotations, were often not identified prior to death, and therefore not documented in the neuroradiology or other medical records. The line dividing &#8220;primary&#8221; malformations from malformations &#8220;secondary&#8221; to disrupted developmental processes is not clear. &#8220;Encephaloclastic&#8221; lesions refer to damages to the fetal brain during the early gestational stage, when macrophages are activated but lack of reactive astrocytosis. Smooth walled cavity, such as porencephaly, hydranencephaly, and multicystic encephalopathy occur as a result. Porencephalic cysts were identified in two of the cases.</p></sec><sec id="bpa13121-sec-0019"><title>Perinatal asphyxia</title><p>Evidences of perinatal hypoxia&#8208;ischemia injuries were found in 8% of the cases. Complex ischemic damages in mixed gray and white matter patterns were observed in cases with a history of &#8220;perinatal asphyxia,&#8221; including ulegyria, status marmoratus, periventricular leukomalacia, and secondary degeneration of the long tracts (Figure&#160;<xref rid="bpa13121-fig-0004" ref-type="fig">4</xref>). There were no significant differences between the SUDEP and non&#8208;SUDEP groups (7.2% and 9.1%, respectively).</p></sec><sec id="bpa13121-sec-0020"><title>Chronic traumatic injury</title><p>Chronic cerebral cortical contusions were found in 11% of all cases included. All cerebral traumas were recorded as &#8220;remote,&#8221; with frontal and temporal lobes being the most common locations.</p></sec><sec id="bpa13121-sec-0021"><title>Tumors</title><p>Interestingly, there was no glioneuronal tumor or other types of long&#8208;term epilepsy&#8208;associated tumor identified in the LHSC cohort. For the two cases where epilepsy was attributed to a CNS tumor, glioblastoma and craniopharyngioma were identified.</p></sec></sec></sec><sec id="bpa13121-sec-0022"><label>3.3.3</label><title>Molecular/genetic findings</title><p>Despite the ever&#8208;growing list of mutations associated with epilepsy and SUDEP, only a minority of cases investigated at the LHSC had genetic testing performed (two cases, 1.3%). Both cases were definite SUDEP, diagnosed after 2014. A targeted &#8220;epilepsy panel&#8221; instead of whole exome sequencing was used. Genetic alterations were detected in both cases. Heterozygous mutations in <italic toggle="yes">KCNH2</italic> and <italic toggle="yes">PRRT2</italic> were detected in one, and mutations in <italic toggle="yes">MTOR</italic>, <italic toggle="yes">PIGG</italic>, and <italic toggle="yes">SYN1</italic> were reported in the second case.</p></sec></sec></sec><sec sec-type="discussion" id="bpa13121-sec-0023"><label>4</label><title>DISCUSSION</title><p>In this study, we reviewed 12,206 autopsies performed at the London Health Sciences Centre over a time frame of 18&#8201;years. A total of 152 deaths occurred in patients with epilepsy. In 97 (64%) of these cases, the cause of death was identified as SUDEP.</p><p>The duration of epilepsy has been proposed as a risk factor for SUDEP. However, our results, as well as others, did not find a significant association [<xref rid="bpa13121-bib-0013" ref-type="bibr">13</xref>, <xref rid="bpa13121-bib-0014" ref-type="bibr">14</xref>, <xref rid="bpa13121-bib-0015" ref-type="bibr">15</xref>]. Generalized seizures, especially generalized tonic&#8211;clonic seizures, were previously reported as a risk factor of SUDEP and were included in the SUDEP&#8208;7 and SUDEP&#8208;3 prediction model [<xref rid="bpa13121-bib-0016" ref-type="bibr">16</xref>, <xref rid="bpa13121-bib-0017" ref-type="bibr">17</xref>]. In our series, the frequency of generalized seizures was significantly higher in SUDEP than non&#8208;SUDEP group.</p><p>In terms of seizure investigation, there were no differences in neuroimaging. In contrast, significantly more EEGs were recorded for patients died of SUDEP than non&#8208;SUDEP. We postulate that frequent EEG monitoring might be an indicator of seizure severity, in keeping with a close follow&#8208;up by a neurologist or an epileptologist.</p><p>Polytherapy was proposed as a possible risk factor for SUDEP [<xref rid="bpa13121-bib-0015" ref-type="bibr">15</xref>, <xref rid="bpa13121-bib-0018" ref-type="bibr">18</xref>]; however, no direct link has been identified with a specific antiseizure medication. In our study, the most documented antiseizure medications were phenytoin, valproic acid, and carbamazepine. <italic toggle="yes">LA Jones et al</italic> commented that carbamazepine and lamotrigine were associated with increased risk of SUDEP [<xref rid="bpa13121-bib-0019" ref-type="bibr">19</xref>], but more data are required to evaluate if these antiseizure medication contributes to risk of SUDEP or if these are confounding factors.</p><p>In relation to other antiseizure management, seven of our SUDEP cases underwent epilepsy surgery, and four of them were investigated with intracranial electrodes. Finally, neuromodulation, including vagus nerve stimulation and deep brain stimulation, has been proposed as a protective factor against SUDEP [<xref rid="bpa13121-bib-0020" ref-type="bibr">20</xref>, <xref rid="bpa13121-bib-0021" ref-type="bibr">21</xref>, <xref rid="bpa13121-bib-0022" ref-type="bibr">22</xref>], but unfortunately, four patients implanted with neuromodulation devices in our study suffered SUDEP [<xref rid="bpa13121-bib-0009" ref-type="bibr">9</xref>]. More data are required to evaluate the efficacy of those devices against SUDEP.</p><p>In accordance with previous reports, epilepsy modality of the Southwestern Ontario cohort peaks between 20 and 50&#8201;years of age [<xref rid="bpa13121-bib-0023" ref-type="bibr">23</xref>, <xref rid="bpa13121-bib-0024" ref-type="bibr">24</xref>, <xref rid="bpa13121-bib-0025" ref-type="bibr">25</xref>, <xref rid="bpa13121-bib-0026" ref-type="bibr">26</xref>, <xref rid="bpa13121-bib-0027" ref-type="bibr">27</xref>, <xref rid="bpa13121-bib-0028" ref-type="bibr">28</xref>, <xref rid="bpa13121-bib-0029" ref-type="bibr">29</xref>, <xref rid="bpa13121-bib-0030" ref-type="bibr">30</xref>]. When compared with non&#8208;SUDEP, the incidence of SUDEP is significantly higher during the second and third decades. Strikingly, this difference is primarily driven by the increased SUDEP rate in male adolescents and young adults (15&#8211;35&#8201;years old).</p><p>The circumstances of death are clearly distinct between SUDEP and non&#8208;SUDEP groups. A significantly higher incidence of SUDEP occurred in the bedroom, either in bed or on floor next to bed. Death in the hospital setting, on the other hand, is more common in the non&#8208;SUDEP group. Prone position is the most common position found for decedents with SUDEP. These findings have been constantly seen in previous studies [<xref rid="bpa13121-bib-0015" ref-type="bibr">15</xref>, <xref rid="bpa13121-bib-0025" ref-type="bibr">25</xref>, <xref rid="bpa13121-bib-0031" ref-type="bibr">31</xref>].</p><p>SUDEP is a diagnosis of exclusion. All other causes of death must be excluded by thorough post&#8208;mortem examination before the final diagnosis of SUDEP is rendered. Neuropathology examination plays important role in identifying potential causes of death, epileptogenic lesions, and secondary changes related to long&#8208;term epilepsy. Currently, there is no standard guideline in Canada for investigation of epilepsy&#8208;related deaths. The 2019 guideline issued by the Royal College of Pathologists (RCP) of the United Kingdom recommended whole brain retention and referral to a neuropathologist as the &#8220;best practice&#8221; for investigating deaths in patients with epilepsy [<xref rid="bpa13121-bib-0032" ref-type="bibr">32</xref>]. It was shown that examination of whole brain post&#8208;fixation has significantly higher yield of detecting epilepsy&#8208;related pathologies [<xref rid="bpa13121-bib-0024" ref-type="bibr">24</xref>]. Prior to June 2010, vast majority of the neuropathology examinations of epilepsy&#8208;related death investigations at LHSC were conducted on fixed whole brain. This is reduced to 7% of the cases after the implementation of <italic toggle="yes">Ontario Coroner Act Regulation</italic>. Interestingly, the number of relevant pathological findings are comparable before and after this regulation implementation, except a decrease in identifying inflammatory/infectious changes. We must acknowledge that neuropathology consultation is a routine practice for our forensic autopsy services when dealing with epilepsy deaths. Neuropathologists usually attend the autopsy to examine the brain freshly and to ensure all essential regions are sampled and examined. However, in agreement with the British RCP recommendation, expert opinion among Canadian Neuropathologists supports that examining fixed brain is markedly superior along multiple lines of measurements including diagnostic sensitivity and accuracy [<xref rid="bpa13121-bib-0033" ref-type="bibr">33</xref>].</p><p>There are no significant differences in the neuropathology findings between SUDEP and non&#8208;SUDEP groups. The neuropathology findings of previous reported series and our cohort are summarized in Table&#160;<xref rid="bpa13121-tbl-0003" ref-type="table">3</xref> [<xref rid="bpa13121-bib-0024" ref-type="bibr">24</xref>, <xref rid="bpa13121-bib-0029" ref-type="bibr">29</xref>, <xref rid="bpa13121-bib-0030" ref-type="bibr">30</xref>, <xref rid="bpa13121-bib-0034" ref-type="bibr">34</xref>, <xref rid="bpa13121-bib-0035" ref-type="bibr">35</xref>]. Of note, death related to perinatal hypoxia&#8208;ischemic brain injuries and malformations occurred at a relatively younger age than the rest of the group (vascular malformation, chronic infarct, tumors, and surgical scars) (Figure&#160;<xref rid="bpa13121-fig-0005" ref-type="fig">5</xref>). Hippocampal sclerosis is identified throughout the entire age span.</p><table-wrap position="float" id="bpa13121-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Review of the previously described neuropathology findings in SUDEP and comparison to the present cohort</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Shields et al. [<xref rid="bpa13121-bib-0029" ref-type="bibr">29</xref>]</th><th align="left" valign="bottom" rowspan="1" colspan="1">Black and Graham [<xref rid="bpa13121-bib-0034" ref-type="bibr">34</xref>]</th><th align="left" valign="bottom" rowspan="1" colspan="1">Zhuo et al. [<xref rid="bpa13121-bib-0030" ref-type="bibr">30</xref>]</th><th align="left" valign="bottom" rowspan="1" colspan="1">Thom et al. [<xref rid="bpa13121-bib-0024" ref-type="bibr">24</xref>]</th><th align="left" valign="bottom" rowspan="1" colspan="1">Leitner et al. [<xref rid="bpa13121-bib-0035" ref-type="bibr">35</xref>]</th><th align="left" valign="bottom" rowspan="1" colspan="1">SWO cohort</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of SUDEP cases</td><td align="left" valign="top" rowspan="1" colspan="1">70</td><td align="left" valign="top" rowspan="1" colspan="1">131</td><td align="left" valign="top" rowspan="1" colspan="1">74</td><td align="left" valign="top" rowspan="1" colspan="1">145</td><td align="left" valign="top" rowspan="1" colspan="1">61</td><td align="left" valign="top" rowspan="1" colspan="1">97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nature of cohort</td><td align="left" valign="top" rowspan="1" colspan="1">Forensic autopsy series, Kentucky, USA</td><td align="left" valign="top" rowspan="1" colspan="1">Forensic autopsy series, Glasgow, UK</td><td align="left" valign="top" rowspan="1" colspan="1">Forensic autopsy series, Maryland, USA</td><td align="left" valign="top" rowspan="1" colspan="1">Neuropathology centers, UK</td><td align="left" valign="top" rowspan="1" colspan="1">NASR, New York, USA</td><td align="left" valign="top" rowspan="1" colspan="1">Forensic autopsy series, Ontario, Canada</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age at death (years)</td><td align="left" valign="top" rowspan="1" colspan="1">16&#8211;71</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8211;74</td><td align="left" valign="top" rowspan="1" colspan="1">14&#8211;63</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8211;82</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8211;57</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8211;72</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male (%)</td><td align="left" valign="top" rowspan="1" colspan="1">54%</td><td align="left" valign="top" rowspan="1" colspan="1">64.1%</td><td align="left" valign="top" rowspan="1" colspan="1">58.1%</td><td align="left" valign="top" rowspan="1" colspan="1">61.1%</td><td align="left" valign="top" rowspan="1" colspan="1">65.6%</td><td align="left" valign="top" rowspan="1" colspan="1">58.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Whole brain examination (%)</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">31.3%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">76.6%</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">43.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Microscopy examination (%)</td><td align="left" valign="top" rowspan="1" colspan="1">73%</td><td align="left" valign="top" rowspan="1" colspan="1">31.3%</td><td align="left" valign="top" rowspan="1" colspan="1">32%</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Brain swelling (%)</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">28.3%</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">6.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cortical malformations (%)</td><td align="left" valign="top" rowspan="1" colspan="1">0%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">6.8%</td><td align="left" valign="top" rowspan="1" colspan="1">14.5%</td><td align="left" valign="top" rowspan="1" colspan="1">42.6%</td><td align="left" valign="top" rowspan="1" colspan="1">17.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vascular malformations (%)</td><td align="left" valign="top" rowspan="1" colspan="1">2.8%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">4.1%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">4.9%</td><td align="left" valign="top" rowspan="1" colspan="1">1.1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mesial temporal sclerosis (%)</td><td align="left" valign="top" rowspan="1" colspan="1">12.8%</td><td align="left" valign="top" rowspan="1" colspan="1">2.29%</td><td align="left" valign="top" rowspan="1" colspan="1">2.7%</td><td align="left" valign="top" rowspan="1" colspan="1">6.9%</td><td align="left" valign="top" rowspan="1" colspan="1">11.5%</td><td align="left" valign="top" rowspan="1" colspan="1">14.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic CNS trauma (%)</td><td align="left" valign="top" rowspan="1" colspan="1">27.1%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">13.5%</td><td align="left" valign="top" rowspan="1" colspan="1">16.6%</td><td align="left" valign="top" rowspan="1" colspan="1">4.9%</td><td align="left" valign="top" rowspan="1" colspan="1">10.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic infarcts (%)</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">2.8%</td><td align="left" valign="top" rowspan="1" colspan="1">13%</td><td align="left" valign="top" rowspan="1" colspan="1">9.8%</td><td align="left" valign="top" rowspan="1" colspan="1">2.1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CNS tumors (%)</td><td align="left" valign="top" rowspan="1" colspan="1">3%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">2.8%</td><td align="left" valign="top" rowspan="1" colspan="1">13%</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cerebellar atrophy (%)</td><td align="left" valign="top" rowspan="1" colspan="1">14.2%</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">5.4%</td><td align="left" valign="top" rowspan="1" colspan="1">40.7%</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">11.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No pathology findings (%)</td><td align="left" valign="top" rowspan="1" colspan="1">54.2%</td><td align="left" valign="top" rowspan="1" colspan="1">34%</td><td align="left" valign="top" rowspan="1" colspan="1">41.9%</td><td align="left" valign="top" rowspan="1" colspan="1">11%</td><td align="left" valign="top" rowspan="1" colspan="1">24.6%</td><td align="left" valign="top" rowspan="1" colspan="1">9.3%</td></tr></tbody></table><table-wrap-foot id="bpa13121-ntgp-0001"><fn id="bpa13121-note-0001"><p>Abbreviations: N/A, not available; NASR, North American SUDEP registry; SWO, Southwestern Ontario.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="bpa13121-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Distribution of age at death based on epilepsy&#8208;associated neuropathological findings. Hippocampal sclerosis is observed in all ages. Premature epilepsy deaths in the first two decades occur in patients with perinatal hypoxic&#8211;ischemic injuries and malformations. Patients with epilepsy secondary to CNS trauma, chronic infarct, tumor, and vascular malformation die at a relatively older age.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="BPA-33-e13121-g001.jpg"/></fig><p>Discordances in SUDEP diagnosis is well recognized [<xref rid="bpa13121-bib-0013" ref-type="bibr">13</xref>]. This is more common for epilepsy decedents with one or more competing or contributing CODs. For example, in this study, majority of patients with severe coronary artery atherosclerosis (more than 70% luminal occlusion of one or more major branches), even without evidence of acute myocardial infarct, the CODs are often attributed to coronary atherosclerosis (non&#8208;SUDEP). Similarly, <italic toggle="yes">Keller et al</italic>. reviewed autopsy reports from the Ontario Forensic Pathology Service over a period of 2.5&#8201;years and compared the Neurologists' assessment and the autopsy&#8208;reported CODs. For SUDEP cases with alternative CODs, <italic toggle="yes">undetermined</italic> or <italic toggle="yes">unascertained</italic> was often reported by Forensic pathologists, with epilepsy included as contributing factor or mentioned in case comments. Neurologists, on the other hand, tend to classify these cases as definite SUDEP plus [<xref rid="bpa13121-bib-0036" ref-type="bibr">36</xref>]. Communication between epileptologists and pathologists, and a standard COD classification are needed for epilepsy&#8208;associated death investigation.</p><p>Despite the emerging concerning of genetic susceptibility to SUDEP, genetic testing is only performed on less than 2% of the cases investigated at LHSC. Genetic testing is not a routine test for epilepsy&#8208;related death investigation and is only conducted upon special requests. Many of SUDEP patients share similar genetic alterations with cardiac arrhythmia [<xref rid="bpa13121-bib-0037" ref-type="bibr">37</xref>, <xref rid="bpa13121-bib-0038" ref-type="bibr">38</xref>, <xref rid="bpa13121-bib-0039" ref-type="bibr">39</xref>, <xref rid="bpa13121-bib-0040" ref-type="bibr">40</xref>, <xref rid="bpa13121-bib-0041" ref-type="bibr">41</xref>]. Interpretation and recommendation based on the genetic findings are challenging because of the limited cases reported.</p><p>We conclude by acknowledging the limitations of this study. One major limitation is the retrospective nature of the data collection. Although many of the epilepsy decedents were seen by neurologists in our center, some of them were referred from nearby communities. We tried our best to enumerate the results; however, there are still many important variables that are unknown. An additional challenge is to obtain detailed information from the coroner's report. The amount of information in these reports varies significantly. Another potential limitation of this study is the long span of the study time period (18&#8201;years). Many recently proposed important pathological findings, such as hippocampal malformations, are not consistently documented in the older autopsy reports. Standardized referral form, practice guideline, and reporting system will improve the data collection and diagnosis accuracy of the often underrecognized epilepsy&#8208;associated death.</p></sec><sec id="bpa13121-sec-0024"><title>AUTHOR CONTRIBUTIONS</title><p>Qi Zhang and Lee&#8208;Cyn Ang contributed to project conceptualization. Qi Zhang, Ana Suller&#8208;Marti, and Jane Jian Ding contributed to data acquisition, data analysis, and text and figures preparation. Jorge G. Burneo, Robert R. Hammond, and Lee&#8208;Cyn Ang contributed to validation, manuscript reviewing, and editing. Gansen Deng and Wenqing He contributed to data analysis.</p></sec><sec sec-type="COI-statement" id="bpa13121-sec-0026"><title>CONFLICT OF INTEREST</title><p>Jorge G. Burneo holds the Jack Cowin Chair in Epilepsy Research from Western University. He also has grant support from Western University, the Ontario Brain Institute, the Rick Berg Foundation, UCB Canada, and Sunovion. The other authors declare no conflict of interest.</p></sec><sec id="bpa13121-sec-0027"><title>ETHICS STATEMENT</title><p>This study was approved by the research ethics board of Western University (HSREB 101967). All cases were investigated at the London Health Sciences Centre (LHSC) under Coroner's warrant or formal autopsy consent.</p></sec></body><back><ack id="bpa13121-sec-0025"><title>ACKNOWLEDGMENTS</title><p>This research was conducted with support from the Epilepsy Research Program (EpLink) of the Ontario Brain Institute, the WSS&#8208;CIHR Seed grant, and the Collaborative Research Seed Grant (CRSG) of Western University, and the Lawson's Research Fund to Qi Zhang. The authors would like to thank the Office of the Chief Coroner (OCC) for Ontario, the Forensic Pathology Team, and the Pathology Translational Research Service of London Health Sciences Centre for assistance with case retrieval and autopsy report reviewing.</p></ack><sec sec-type="data-availability" id="bpa13121-sec-0029"><title>DATA AVAILABILITY STATEMENT</title><p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></sec><ref-list id="bpa13121-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="bpa13121-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="bpa13121-cit-0001"><string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name>. <article-title>Deaths in epilepsy what we are missing</article-title>. <source>JAMA Neurol</source>. <year>2018</year>;<volume>75</volume>:<fpage>1</fpage>&#8211;<lpage>3</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2018.0002</pub-id><pub-id pub-id-type="pmid">29630704</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="bpa13121-cit-0002"><string-name name-style="western"><surname>Gorton</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Webb</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Carr</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>DelPozo&#8208;Banos</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>John</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ashcroft</surname><given-names>DM</given-names></string-name>. <article-title>Risk of unnatural mortality in people with epilepsy</article-title>. <source>JAMA Neurol</source>. <year>2018</year>;<volume>75</volume>:<fpage>929</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="pmid">29630689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2018.0333</pub-id><pub-id pub-id-type="pmcid">PMC6075702</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="bpa13121-cit-0003"><string-name name-style="western"><surname>Nashef</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>So</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Ryvlin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Tomson</surname><given-names>T</given-names></string-name>. <article-title>Unifying the definitions of sudden unexpected death in epilepsy</article-title>. <source>Epilepsia</source>. <year>2012</year>;<volume>53</volume>(<issue>2</issue>):<fpage>227</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">22191982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1528-1167.2011.03358.x</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="bpa13121-cit-0004"><string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Hesdorffer</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Thurman</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Lhatoo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Richerson</surname><given-names>G</given-names></string-name>. <article-title>Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention</article-title>. <source>Lancet Neurol</source>. <year>2016</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1075</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="pmid">27571159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(16)30158-2</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="bpa13121-cit-0005"><string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Bundock</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hesdorffer</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Donner</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Moseley</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Cihan</surname><given-names>E</given-names></string-name>, et al. <article-title>Resolving ambiguities in SUDEP classification</article-title>. <source>Epilepsia</source>. <year>2018</year>;<volume>59</volume>(<issue>6</issue>):<fpage>1220</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">29791724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.14195</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="bpa13121-cit-0006"><string-name name-style="western"><surname>Schraeder</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Delin</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>McClelland</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>So</surname><given-names>EL</given-names></string-name>. <article-title>Coroner and medical examiner documentation of sudden unexplained deaths in epilepsy</article-title>. <source>Epilepsy Res</source>. <year>2006</year>;<volume>68</volume>(<issue>2</issue>):<fpage>137</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">16423504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eplepsyres.2005.10.004</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="bpa13121-cit-0007"><string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Donner</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Stephens</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>. <article-title>Sudden unexpected death in epilepsy: knowledge and experience among U.S. and Canadian neurologists</article-title>. <source>Epilepsy Behav</source>. <year>2014</year>;<volume>35</volume>:<fpage>13</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24785429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2014.03.022</pub-id><pub-id pub-id-type="pmcid">PMC4176608</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="bpa13121-cit-0008"><string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Joodi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Sadaf</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Pursell</surname><given-names>IW</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>RJ</given-names></string-name>. <article-title>Under&#8208;reporting of sudden unexpected death in epilepsy</article-title>. <source>Epileptic Disord</source>. <year>2018</year>;<volume>20</volume>(<issue>4</issue>):<fpage>270</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30078774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1684/epd.2018.0979</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="bpa13121-cit-0009"><string-name name-style="western"><surname>Ding</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rebernig</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Suller&#8208;Marti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Parrent</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Burneo</surname><given-names>JG</given-names></string-name>, et al. <article-title>Vagus nerve stimulation does not alter brainstem nuclei morphology in patients with refractory epilepsy</article-title>. <source>Epilepsy Behav</source>. <year>2021</year>;<volume>118</volume>:<elocation-id>107940</elocation-id>.<pub-id pub-id-type="pmid">33838622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2021.107940</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="bpa13121-cit-0010"><string-name name-style="western"><surname>Kinney</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Poduri</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Cryan</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Haynes</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Teot</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sleeper</surname><given-names>LA</given-names></string-name>, et al. <article-title>Hippocampal formation maldevelopment and sudden unexpected death across the pediatric age spectrum</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>2016</year>;<volume>75</volume>:<fpage>981</fpage>&#8211;<lpage>97</lpage>.<pub-id pub-id-type="pmid">27612489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnen/nlw075</pub-id><pub-id pub-id-type="pmcid">PMC6281079</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="bpa13121-cit-0011"><string-name name-style="western"><surname>Hefti</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Cryan</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Haas</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Chadwick</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Crandall</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Trachtenberg</surname><given-names>FL</given-names></string-name>, et al. <article-title>Hippocampal malformation associated with sudden death in early childhood: a neuropathologic study: part 2 of the investigations of the San Diego SUDC Research Project</article-title>. <source>Forensic Sci Med Pathol</source>. <year>2016</year>;<volume>12</volume>(<issue>1</issue>):<fpage>14</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">26782962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12024-015-9731-3</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="bpa13121-cit-0012"><string-name name-style="western"><surname>Somani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Zborovschi</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Patodia</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Michalak</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Sisodiya</surname><given-names>SM</given-names></string-name>, et al. <article-title>Hippocampal morphometry in sudden and unexpected death in epilepsy</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>93</volume>(<issue>8</issue>):<fpage>e804</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">31345959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000007969</pub-id><pub-id pub-id-type="pmcid">PMC6711661</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="bpa13121-cit-0013"><string-name name-style="western"><surname>Verducci</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Donner</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Laze</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>. <article-title>SUDEP classification: discordances between forensic investigators and epileptologists</article-title>. <source>Epilepsia</source>. <year>2020</year>;<volume>61</volume>:<fpage>e173</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">33063853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.16712</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="bpa13121-cit-0014"><string-name name-style="western"><surname>Novak</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Markovic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Meymandi</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>DeGiorgio</surname><given-names>CM</given-names></string-name>. <article-title>Risk assessment for sudden death in epilepsy: the SUDEP&#8208;7 inventory</article-title>. <source>Front Neurol</source>. <year>2015</year>;<volume>6</volume>:<elocation-id>252</elocation-id>.<pub-id pub-id-type="pmid">26696953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2015.00252</pub-id><pub-id pub-id-type="pmcid">PMC4673971</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="bpa13121-cit-0015"><string-name name-style="western"><surname>Opeskin</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Berkovic</surname><given-names>SF</given-names></string-name>. <article-title>Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases</article-title>. <source>Seizure</source>. <year>2003</year>;<volume>12</volume>(<issue>7</issue>):<fpage>456</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">12967573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1059-1311(02)00352-7</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="bpa13121-cit-0016"><string-name name-style="western"><surname>Harden</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tomson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Gloss</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Buchhalter</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cross</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Donner</surname><given-names>E</given-names></string-name>, et al. <article-title>Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>88</volume>(<issue>17</issue>):<fpage>1674</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">28438841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000003685</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="bpa13121-cit-0017"><string-name name-style="western"><surname>Tarighati Rasekhi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Devlin</surname><given-names>KN</given-names></string-name>, <string-name name-style="western"><surname>Mass</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Donmez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Asma</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sperling</surname><given-names>MR</given-names></string-name>, et al. <article-title>Improving prediction of sudden unexpected death in epilepsy: from SUDEP&#8208;7 to SUDEP&#8208;3</article-title>. <source>Epilepsia</source>. <year>2021</year>;<volume>62</volume>:<fpage>1536</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="pmid">34086290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.16928</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="bpa13121-cit-0018"><string-name name-style="western"><surname>Annegers</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Coan</surname><given-names>SP</given-names></string-name>. <article-title>SUDEP: overview of definitions and review of incidence data</article-title>. <source>Seizure</source>. <year>1999</year>;<volume>8</volume>(<issue>6</issue>):<fpage>347</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">10512776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/seiz.1999.0306</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="bpa13121-cit-0019"><string-name name-style="western"><surname>Jones</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>RH</given-names></string-name>. <article-title>Sudden death in epilepsy: insights from the last 25&#8201;years</article-title>. <source>Seizure</source>. <year>2017</year>;<volume>44</volume>:<fpage>232</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">27773556</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.seizure.2016.10.002</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="bpa13121-cit-0020"><string-name name-style="western"><surname>Kawai</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Baba</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Bunker</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ikeda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Inoue</surname><given-names>Y</given-names></string-name>, et al. <article-title>Outcome of vagus nerve stimulation for drug&#8208;resistant epilepsy: the first three years of a prospective Japanese registry</article-title>. <source>Epileptic Disord</source>. <year>2017</year>;<volume>19</volume>(<issue>3</issue>):<fpage>327</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="pmid">28832004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1684/epd.2017.0929</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="bpa13121-cit-0021"><string-name name-style="western"><surname>Krahl</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname><given-names>KB</given-names></string-name>. <article-title>Vagus nerve stimulation for epilepsy: a review of central mechanisms</article-title>. <source>Surg Neurol Int</source>. <year>2012</year>;<volume>3</volume>(<issue>suppl 4</issue>):<fpage>S255</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23230530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/2152-7806.103015</pub-id><pub-id pub-id-type="pmcid">PMC3514919</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="bpa13121-cit-0022"><string-name name-style="western"><surname>Schulze&#8208;Bonhage</surname><given-names>A</given-names></string-name>. <article-title>Long&#8208;term outcome in neurostimulation of epilepsy</article-title>. <source>Epilepsy &amp; Behavior</source>. <year>2018</year>;<volume>91</volume>:<fpage>25</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2018.06.011</pub-id><pub-id pub-id-type="pmid">30929666</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="bpa13121-cit-0023"><string-name name-style="western"><surname>Verducci</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hussain</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Donner</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Moseley</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Buchhalter</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hesdorffer</surname><given-names>D</given-names></string-name>, et al. <article-title>SUDEP in the North American SUDEP registry</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>93</volume>:<fpage>e227</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000007778</pub-id><pub-id pub-id-type="pmid">31217259</pub-id><pub-id pub-id-type="pmcid">PMC6656646</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="bpa13121-cit-0024"><string-name name-style="western"><surname>Thom</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Michalak</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Dawson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hilton</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Joshi</surname><given-names>A</given-names></string-name>, et al. <article-title>Audit of practice in sudden unexpected death in epilepsy (SUDEP) post mortems and neuropathological findings</article-title>. <source>Neuropathol Appl Neurobiol</source>. <year>2016</year>;<volume>42</volume>(<issue>5</issue>):<fpage>463</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">26300477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/nan.12265</pub-id><pub-id pub-id-type="pmcid">PMC4864133</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="bpa13121-cit-0025"><string-name name-style="western"><surname>Karlovich</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Brandsoy</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name>. <article-title>SUDEP among young adults in the San Diego County medical examiner office</article-title>. <source>Epilepsia</source>. <year>2020</year>;<volume>61</volume>:<fpage>e17</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">32030739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.16443</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="bpa13121-cit-0026"><string-name name-style="western"><surname>Melez</surname><given-names>IE</given-names></string-name>, <string-name name-style="western"><surname>Arslan</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Melez</surname><given-names>DO</given-names></string-name>, <string-name name-style="western"><surname>Sanli</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Koc</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Esen Melez</surname><given-names>I</given-names></string-name>, et al. <article-title>Sudden unexpected death in epilepsy: a retrospective autopsy study of 112 epileptic patients</article-title>. <source>Noro Psikiyatr Ars</source>. <year>2016</year>;<volume>54</volume>(<issue>3</issue>):<fpage>225</fpage>&#8211;<lpage>33</lpage>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.noropsikiyatriarsivi.com/eng/makale/3517/427/Full-Text" ext-link-type="uri">http://www.noropsikiyatriarsivi.com/eng/makale/3517/427/Full-Text</ext-link><pub-id pub-id-type="pmid">29033634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5152/npa.2016.14863</pub-id><pub-id pub-id-type="pmcid">PMC5630100</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="bpa13121-cit-0027"><string-name name-style="western"><surname>Thorn</surname><given-names>M</given-names></string-name>. <article-title>Neuropathologic findings in postmortem studies of sudden death in epilepsy</article-title>. <source>Epilepsia</source>. <year>1997</year>;<volume>38</volume>(<issue>11 suppl</issue>):<fpage>S32</fpage>&#8211;<lpage>4</lpage>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19909322" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/19909322</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1528-1157.1997.tb06123.x</pub-id><pub-id pub-id-type="pmid">19909322</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="bpa13121-cit-0028"><string-name name-style="western"><surname>Black</surname><given-names>M</given-names></string-name>. <article-title>Sudden unexplained death in adults caused by intracranial pathology</article-title>. <source>J Clin Pathol</source>. <year>2002</year>;<volume>55</volume>:<fpage>44</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="pmid">11825924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jcp.55.1.44</pub-id><pub-id pub-id-type="pmcid">PMC1769576</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="bpa13121-cit-0029"><string-name name-style="western"><surname>Shields</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hunsaker</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Hunsaker</surname><given-names>JC</given-names><suffix>3rd</suffix></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>JC</given-names><suffix>Jr</suffix></string-name>. <article-title>Sudden unexpected death in epilepsy: neuropathologic findings</article-title>. <source>Am J Forensic Med Pathol</source>. <year>2002</year>;<volume>23</volume>(<issue>4</issue>):<fpage>307</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">12464802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000433-200212000-00001</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="bpa13121-cit-0030"><string-name name-style="western"><surname>Zhuo</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zielke</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Levine</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>L</given-names></string-name>, et al. <article-title>Sudden unexpected death in epilepsy: evaluation of forensic autopsy cases</article-title>. <source>Forensic Sci Int</source>. <year>2012</year>;<volume>223</volume>(<issue>1&#8211;3</issue>):<fpage>171</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">22999232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.forsciint.2012.08.024</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="bpa13121-cit-0031"><string-name name-style="western"><surname>Sveinsson</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Andersson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Carlsson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tomson</surname><given-names>T</given-names></string-name>. <article-title>Circumstances of SUDEP: a nationwide population&#8208;based case series</article-title>. <source>Epilepsia</source>. <year>2018</year>;<volume>59</volume>(<issue>5</issue>):<fpage>1074</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">29663344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.14079</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="bpa13121-cit-0032"><string-name name-style="western"><surname>Thom</surname><given-names>M.</given-names></string-name><article-title>Guidelines on autopsy practice: Deaths in patients with epilepsy including sudden deaths Unique document number G175 Document name Guidelines on autopsy practice: Deaths in patients with epilepsy including sudden deaths</article-title>. <year>2019</year> [cited 2022 Sep 27]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.rcpath.org/uploads/assets/15a26420-ce7b-4858-ad538b210328d973/G175-Guidelines-on-autopsy-practice-Deaths-in-patients-with-epilepsy-including-sudden-deaths.pdf" ext-link-type="uri">https://www.rcpath.org/uploads/assets/15a26420&#8208;ce7b&#8208;4858&#8208;ad538b210328d973/G175&#8208;Guidelines&#8208;on&#8208;autopsy&#8208;practice&#8208;Deaths&#8208;in&#8208;patients&#8208;with&#8208;epilepsy&#8208;including&#8208;sudden&#8208;deaths.pdf</ext-link></mixed-citation></ref><ref id="bpa13121-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="bpa13121-cit-0033"><string-name name-style="western"><surname>Hammond</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Dunham</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>McFadden</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Del Bigio</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Perez&#8208;Rosendahl</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vinters</surname><given-names>HV</given-names></string-name>. <article-title>Postmortem examination of the nervous system: fresh vs fixed</article-title>. <source>Can J Neurol Sci</source>. <year>2021</year>;<volume>49</volume>:<fpage>583</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">34289921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/cjn.2021.181</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="bpa13121-cit-0034"><string-name name-style="western"><surname>Black</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>DI</given-names></string-name>. <article-title>Sudden unexplained death in adults caused by intracranial pathology</article-title>. <source>J Clin Pathol</source>. <year>2002</year>;<volume>55</volume>(<issue>1</issue>):<fpage>44</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="pmid">11825924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jcp.55.1.44</pub-id><pub-id pub-id-type="pmcid">PMC1769576</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="bpa13121-cit-0035"><string-name name-style="western"><surname>Leitner</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Faustin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Verducci</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>William</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Devore</surname><given-names>S</given-names></string-name>, et al. <article-title>Neuropathology in the North American sudden unexpected death in epilepsy registry</article-title>. <source>Brain Commun</source>. <year>2021</year>;<volume>3</volume>(<issue>3</issue>):<elocation-id>fcab192</elocation-id>.<pub-id pub-id-type="pmid">34514397</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/braincomms/fcab192</pub-id><pub-id pub-id-type="pmcid">PMC8417454</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="bpa13121-cit-0036"><string-name name-style="western"><surname>Keller</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Ho</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Whitney</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Pollanen</surname><given-names>MS</given-names></string-name>, et al. <article-title>Autopsy&#8208;reported cause of death in a population&#8208;based cohort of sudden unexpected death in epilepsy</article-title>. <source>Epilepsia</source>. <year>2021</year>;<volume>62</volume>(<issue>2</issue>):<fpage>472</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">33400291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.16793</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="bpa13121-cit-0037"><string-name name-style="western"><surname>Thom</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Boldrini</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bundock</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Sheppard</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></string-name>. <article-title>Review: the past, present and future challenges in epilepsy&#8208;related and sudden deaths and biobanking</article-title>. <source>Neuropathol Appl Neurobiol</source>. <year>2018</year>;<volume>44</volume>(<issue>1</issue>):<fpage>32</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="pmid">29178443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/nan.12453</pub-id><pub-id pub-id-type="pmcid">PMC5820128</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="bpa13121-cit-0038"><string-name name-style="western"><surname>Tu</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bagnall</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Duflou</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Semsarian</surname><given-names>C</given-names></string-name>. <article-title>Post&#8208;mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases</article-title>. <source>Brain Pathol</source>. <year>2011</year>;<volume>21</volume>(<issue>2</issue>):<fpage>201</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">20875080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1750-3639.2010.00438.x</pub-id><pub-id pub-id-type="pmcid">PMC8094243</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="bpa13121-cit-0039"><string-name name-style="western"><surname>Bagnall</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Crompton</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Petrovski</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cutmore</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Garry</surname><given-names>SI</given-names></string-name>, et al. <article-title>Exome&#8208;based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy</article-title>. <source>Ann Neurol</source>. <year>2016</year>;<volume>79</volume>(<issue>4</issue>):<fpage>522</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">26704558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.24596</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="bpa13121-cit-0040"><string-name name-style="western"><surname>Bagnall</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Crompton</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Semsarian</surname><given-names>C</given-names></string-name>. <article-title>Genetic basis of sudden unexpected death in epilepsy</article-title>. <source>Front Neurol</source>. <year>2017</year>;<volume>8</volume>:<elocation-id>348</elocation-id>.<pub-id pub-id-type="pmid">28775708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2017.00348</pub-id><pub-id pub-id-type="pmcid">PMC5517398</pub-id></mixed-citation></ref><ref id="bpa13121-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="bpa13121-cit-0041"><string-name name-style="western"><surname>Coll</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Allegue</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Partemi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mates</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Del Olmo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Campuzano</surname><given-names>O</given-names></string-name>, et al. <article-title>Genetic investigation of sudden unexpected death in epilepsy cohort by panel target resequencing</article-title>. <source>Int J Leg Med</source>. <year>2016</year>;<volume>130</volume>(<issue>2</issue>):<fpage>331</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00414-015-1269-0</pub-id><pub-id pub-id-type="pmid">26423924</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>